Leukocyte immunoglobulin-like receptors as new players in autoimmunity

R Thomas, T Matthias, T Witte - Clinical reviews in allergy & immunology, 2010 - Springer
R Thomas, T Matthias, T Witte
Clinical reviews in allergy & immunology, 2010Springer
Leukocyte immunoglobulin-like receptors (LILR) are a family of at least 13 receptors mainly
expressed on lymphoid and myelomonocytic cells. They are involved in the activation of the
immune system. Inhibitory LILR (termed LILRB) signal through immunoreceptor tyrosine-
based inhibitory motives in the cytoplasmic domain, whereas LILRA with short cytoplasmic
domains are stimulatory receptors. Polymorphisms and deletions of leukocyte
immunoglobulin-like receptors have been shown to be associated with autoimmune …
Abstract
Leukocyte immunoglobulin-like receptors (LILR) are a family of at least 13 receptors mainly expressed on lymphoid and myelomonocytic cells. They are involved in the activation of the immune system. Inhibitory LILR (termed LILRB) signal through immunoreceptor tyrosine-based inhibitory motives in the cytoplasmic domain, whereas LILRA with short cytoplasmic domains are stimulatory receptors. Polymorphisms and deletions of leukocyte immunoglobulin-like receptors have been shown to be associated with autoimmune disorders, and some of the receptors are involved in the generation of regulatory T cells. Therefore, leukocyte immunoglobulin-like receptors may be central in the pathogenesis of autoimmunity. The data linking these receptors to autoimmune diseases is reviewed here.
Springer